Skip Navigation

China’s new cancer drug is approved in the US but will cost 30 times more: US$280 in China, US$8,892 in the US

www.scmp.com US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.

US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval
14

You're viewing a single thread.

14 comments
You've viewed 14 comments.